Drug Discovery Solutions
-
Analytical Labs Particle Analysis
Particulate in a drug product represents a huge risk not only to patient safety – but also to a drug company’s reputation and bottom line. As concern about particulate rises, partnering with a particle analysis team enables customers to gain an intimate understanding of particle sources related to packaging and delivery systems.
-
Expediting Drug Discovery From Concept To Commercialization
8/13/2024
Explore a suite of services designed to accelerate drug discovery and development, from custom reagent production and high-throughput screening to advanced in vitro pharmacology and DMPK assays.
-
PUREplatform PUREcoli, A Pure Microbial Strain For Protein Production
3/17/2023
PUREplatform offers a platform, a premium strain, and cutting-edge screening, which together yield optimal protein expression that is uniquely tailored to each project.
-
Early Phase Bioassays And Analytics
6/26/2024
The development of phase-appropriate, tailored bioassays is crucial. By identifying promising candidates, bioassays streamline the development process, enabling informed decision-making.
-
Accelerating CHO Bulk Harvest Testing Requires Rapid Methods
1/14/2026
Reduce testing timelines from weeks to days with advanced viral detection, as well as achieve faster lot release and regulatory alignment while maintaining safety and compliance for CHO-based processes.
-
The Essential Role Of High-Quality Anti-Host Cell Protein (HCP) Antibody Reagents
9/13/2025
Advance biopharmaceutical development with robust HCP detection strategies and high-quality antibody reagents to ensure product purity, safety, and regulatory compliance.